Journal of Medicinal Chemistry 1987-11-01

Synthesis and antiinflammatory activities of 3-(3,5-di-tert-butyl-4-hydroxybenzylidene)pyrrolidin-2-ones.

H Ikuta, H Shirota, S Kobayashi, Y Yamagishi, K Yamada, I Yamatsu, K Katayama

Index: J. Med. Chem. 30 , 1995, (1987)

Full Text: HTML

Abstract

A series of 3-(3,5-di-tert-butyl-4-hydroxybenzylidene)pyrrolidin-2-ones was synthesized and evaluated as candidate antiinflammatory/analgesic agents as well as dual inhibitors of prostaglandin and leukotriene synthesis. Some compounds that showed dual inhibitory activity were found to possess equipotent antiinflammatory activities to indomethacin, with reduced ulcerogenic effects. One of the compounds, N-methoxy-3-(3,5-di-tert-butyl-4-hydroxybenzylidene)pyrrolidin-2-o ne, was found to have a wider safety margin than indomethacin or piroxicam, and was selected for detailed evaluation as a candidate drug for clinical application.


Related Compounds

Related Articles:

Design, synthesis and characterization of a highly effective inhibitor for analog-sensitive (as) kinases.

2011-01-01

[PLoS ONE 6(6) , e20789, (2011)]

B. Son et al.

[Synthesis , 776, (1984)]

H.G. Löhr, F. Vögtle

[Chem. Ber. 118 , 914, (1985)]

More Articles...